acute dyspnea. Dyspnea
Conditions
Interventions
Intervention 1: Intervention group: 40 milligram of Furosemide is inhaled through nebulizer in addition to routine treatment in ambulances. Intervention 2: Control group: Normal Saline as a placebo wi
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: all patient between 18 to 75 years old with dyspnea who transmitted to hospitals by EMS
Exclusion criteria
Exclusion criteria: not willing to participate in the study history of susceptibility to sulfa drugs unstable hemodynamics; requiring mechanical ventilation; decreased consciousness, accompany with another illness requiring treatment in the first 10 minutes of treatment with digoxin, beta blocker, beta-agonist and calcium; need to have another inhaling treatment in the first 10 minutes and need to have non-invasive ventilation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygen saturation. Timepoint: baseline until arrive to hospital. Method of measurement: Pulse oximeter.;MMRC Dyspnea Severity Scale. Timepoint: baseline until arrive to hospital. Method of measurement: Visual Analouge Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of dyspnea. Timepoint: baseline until to arrive to hospital. Method of measurement: visual analogue scale by EMS staff. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Mahshidfar
Iran University of Medical Sciences
Outcome results
None listed